Mikrobielle Pathogenitätsmechanismen

Mavor AL, Thewes S, Hube B (2005) Systemic fungal infections caused by Candida species: epidemiology, infection process and virulence attributes. Curr Drug Targets 6(8), 863-874.

Schaller M, Borelli C, Korting HC, Hube B (2005) Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses 48(6), 365-377. (Review)

Schaller M, Korting HC, Borelli C, Hamm G, Hube B (2005) Candida albicans-secreted aspartic proteinases modify the epithelial cytokine response in an in vitro model of vaginal candidiasis. Infect Immun 73(5), 2758-2765.

Sigle HC, Thewes S, Niewerth M, Korting HC, Schäfer-Korting M, Hube B (2005) Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans. J Antimicrob Chemother 55(5), 663-673.

Fradin C, Thewes S, Zakikhany K, Albrecht A, Bader O, Kunze D, Hube B (2004) Transcriptional profiling of Candida albicans during infections. Mikologia Lekarska 11, 157-163. (Review)

Hube B (2004) From commensal to pathogen: stage- and tissue-specific gene expression of Candida albicans. Curr Opin Microbiol 7(4), 336-341. (Review)

Moran G, Stokes C, Thewes S, Hube B, Coleman DC, Sullivan D (2004) Comparative genomics using Candida albicans DNA microarrays reveals absence and divergence of virulence-associated genes in Candida dubliniensis. Microbiology 150(Pt 10), 3363-3382.

Naglik J, Albrecht A, Bader O, Hube B (2004) Candida albicans proteinases and host/pathogen interactions. Cell Microbiol 6(10), 915-926. (Review)

Schaller M, Boeld U, Oberbauer S, Hamm G, Hube B, Korting HC (2004) Polymorphonuclear leukocytes (PMNs) induce protective Th1-type cytokine epithelial responses in an in vitro model of oral candidosis. Microbiology 150(Pt 9), 2807-2813.

Schaller M, Hube B (2004) Candida albicans-Infektionsmodelle. Bioforum 11, 2-3. (Review)